Day Zero Diagnostics

Developer of genome sequencing-based diagnostics for infectious diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2016 groups52 employees language dayzerodiagnostics.com

Registered entities

Investor mix

12 investors on record; lead investors include Golden Seeds, Sands Capital Ventures, Triventures, Sands Capital.

Investor typeCountShare
Venture capital542%
Private equity18%
Accelerator & incubator18%
Other / undisclosed542%
Coming soon